Advisors Capital Management LLC Has $3.41 Million Stock Holdings in Solventum Corporation $SOLV

Key Points

• Advisors Capital Management LLC increased its stake in Solventum Corporation by 43.6% during the first quarter, bringing their total holdings to 44,901 shares valued at approximately $3.41 million.
• In recent analyst ratings, Piper Sandler set a new price objective of $94.00, while Morgan Stanley raised its target to $103.00, indicating a generally positive outlook on the stock.
• Solventum reported strong financial results, with an earnings per share of $1.69 for the recent quarter, exceeding analyst expectations and marking a year-over-year increase in revenue of 3.8%.

Advisors Capital Management LLC raised its holdings in Solventum Corporation (NYSE:SOLV - Free Report) by 43.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,901 shares of the company's stock after acquiring an additional 13,625 shares during the quarter. Advisors Capital Management LLC's holdings in Solventum were worth $3,414,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in SOLV. Rossby Financial LCC acquired a new stake in Solventum in the first quarter valued at approximately $25,000. Strengthening Families & Communities LLC lifted its stake in Solventum by 376.8% in the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock valued at $25,000 after acquiring an additional 260 shares during the last quarter. Raiffeisen Bank International AG acquired a new stake in Solventum in the fourth quarter valued at approximately $29,000. Hara Capital LLC acquired a new stake in shares of Solventum in the first quarter worth $38,000. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Solventum by 193.4% in the first quarter. Smartleaf Asset Management LLC now owns 534 shares of the company's stock worth $40,000 after buying an additional 352 shares during the last quarter.

Analyst Ratings Changes

SOLV has been the subject of a number of analyst reports. Piper Sandler restated an "overweight" rating and issued a $94.00 price objective (up from $87.00) on shares of Solventum in a research note on Friday, August 8th. Argus upgraded shares of Solventum from a "hold" rating to a "buy" rating and set a $90.00 price objective for the company in a research note on Tuesday, July 1st. Wall Street Zen cut shares of Solventum from a "strong-buy" rating to a "buy" rating in a research note on Tuesday. Jefferies Financial Group initiated coverage on shares of Solventum in a research note on Thursday. They issued a "hold" rating and a $80.00 price objective for the company. Finally, Morgan Stanley upgraded shares of Solventum from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $80.00 to $103.00 in a research note on Tuesday, July 15th. Four analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $85.11.

Solventum Trading Down 0.6%

Shares of SOLV stock opened at $73.32 on Friday. Solventum Corporation has a 1 year low of $60.70 and a 1 year high of $85.92. The firm's fifty day simple moving average is $73.09 and its 200 day simple moving average is $72.66. The firm has a market capitalization of $12.71 billion, a P/E ratio of 33.95, a price-to-earnings-growth ratio of 3.02 and a beta of 0.53. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.14.

Solventum (NYSE:SOLV - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.45 by $0.24. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The business had revenue of $2.16 billion for the quarter, compared to analyst estimates of $2.12 billion. During the same quarter in the previous year, the firm posted $1.56 earnings per share. Solventum's revenue was up 3.8% compared to the same quarter last year. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, sell-side analysts predict that Solventum Corporation will post 6.58 EPS for the current year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Corporation (NYSE:SOLV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.